Prudo Ray

Director at Akari Therapeutics Plc · on record since Sep 23, 2015
10% owner at Akari Therapeutics Plc · on record since Sep 23, 2015

Insider trading activity of Prudo Ray

Transactions on record: 14; since Jun 4, 2024

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Dec 18, 2025

Figures computed from official regulatory filings — .

Companies where Prudo Ray has traded

Akari Therapeutics Plc14 tx · $1.9M · Dec 18, 2025

Track record of Prudo Ray

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Prudo Ray

Co-insiders of Prudo Ray

Bazemore Robert BAkari Therapeutics Plc
Byrne DavidAkari Therapeutics Plc
Cohen Mark SAkari Therapeutics Plc
DICICCO WENDY FAkari Therapeutics Plc
Doman Robert FAkari Therapeutics Plc
EIRAN AIMOSAkari Therapeutics Plc
Elefant DovAkari Therapeutics Plc
Farag Kameel D.Akari Therapeutics Plc
Gaslightwala AbizerAkari Therapeutics Plc
Grissinger MichaelAkari Therapeutics Plc
Hashad Mohamed Wa'el AhmedAkari Therapeutics Plc
Hill JamesAkari Therapeutics Plc
Hombeck TorstenAkari Therapeutics Plc
Huh HoyoungAkari Therapeutics Plc
Jacques Rachelle SuzanneAkari Therapeutics Plc
Jimenez PabloAkari Therapeutics Plc
LAU JOHNSON YIU NAMAkari Therapeutics Plc
Mintz HalAkari Therapeutics Plc
Neal James RAkari Therapeutics Plc
Patel Samir RashmikantAkari Therapeutics Plc
Patel Sandip IAkari Therapeutics Plc
Richardson CliveAkari Therapeutics Plc
Roshwalb GurAkari Therapeutics Plc
RPC Pharma LtdAkari Therapeutics Plc
Sabby Healthcare Volatility Master Fund, Ltd.Akari Therapeutics Plc
SABBY MANAGEMENT, LLCAkari Therapeutics Plc
Shaw AllanAkari Therapeutics Plc
SHAW ROBERT MAkari Therapeutics Plc
SIDRANSKY DAVIDAkari Therapeutics Plc
Ungar StuartAkari Therapeutics Plc

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Akari Therapeutics PlcListing on record	Dec 18, 2025	BuyD (derivative)	618,658	0.40 USD	$247.5K	ClusterFirst in 12mo	SEC
Akari Therapeutics PlcListing on record	Dec 18, 2025	BuyD (derivative)	386,661	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
Akari Therapeutics PlcListing on record	Dec 18, 2025	BuyD (derivative)	386,661	0.40 USD	$154.7K	ClusterFirst in 12mo	SEC
Akari Therapeutics PlcListing on record	Dec 18, 2025	BuyD (derivative)	618,658	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
Akari Therapeutics PlcListing on record	Mar 24, 2025	AwardD (derivative)	225,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akari Therapeutics PlcListing on record	Mar 24, 2025	AwardD (derivative)	175,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akari Therapeutics PlcListing on record	Mar 10, 2025	AwardD (derivative)	446,428	1.12 USD	$500K		SEC
Akari Therapeutics PlcListing on record	Mar 10, 2025	AwardD (derivative)	446,428	1.12 USD	$500K		SEC
Akari Therapeutics PlcListing on record	Mar 10, 2025	Award	446,428	1.12 USD	$500K		SEC
Akari Therapeutics PlcListing on record	Dec 3, 2024	AwardD (derivative)	419,286,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akari Therapeutics PlcListing on record	Dec 3, 2024	Award	419,286,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akari Therapeutics PlcListing on record	Jul 2, 2024	AwardD (derivative)	10,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akari Therapeutics PlcListing on record	Jun 4, 2024	Award	1,326,258,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akari Therapeutics PlcListing on record	Jun 4, 2024	AwardD (derivative)	1,326,258,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Akari Therapeutics PlcListing on record	Dec 18, 2025	BuyD (derivative)	618,658	0.40 USD	$247.5K	ClusterFirst in 12mo	SEC
Akari Therapeutics PlcListing on record	Dec 18, 2025	BuyD (derivative)	386,661	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
Akari Therapeutics PlcListing on record	Dec 18, 2025	BuyD (derivative)	386,661	0.40 USD	$154.7K	ClusterFirst in 12mo	SEC
Akari Therapeutics PlcListing on record	Dec 18, 2025	BuyD (derivative)	618,658	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
Akari Therapeutics PlcListing on record	Mar 24, 2025	AwardD (derivative)	225,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akari Therapeutics PlcListing on record	Mar 24, 2025	AwardD (derivative)	175,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akari Therapeutics PlcListing on record	Mar 10, 2025	AwardD (derivative)	446,428	1.12 USD	$500K		SEC
Akari Therapeutics PlcListing on record	Mar 10, 2025	AwardD (derivative)	446,428	1.12 USD	$500K		SEC
Akari Therapeutics PlcListing on record	Mar 10, 2025	Award	446,428	1.12 USD	$500K		SEC
Akari Therapeutics PlcListing on record	Dec 3, 2024	AwardD (derivative)	419,286,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akari Therapeutics PlcListing on record	Dec 3, 2024	Award	419,286,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akari Therapeutics PlcListing on record	Jul 2, 2024	AwardD (derivative)	10,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akari Therapeutics PlcListing on record	Jun 4, 2024	Award	1,326,258,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akari Therapeutics PlcListing on record	Jun 4, 2024	AwardD (derivative)	1,326,258,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC